These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6775384)

  • 21. [Bismuth encephalopathy in pregnant women. Apropos of a case].
    Quéreux C; Morice J; Level G; Ezes H; Wahl P
    J Gynecol Obstet Biol Reprod (Paris); 1976; 5(1):97-103. PubMed ID: 956618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter: Digestive resorption in man of different insoluble bismuth salts].
    Conso F; Bourdon R; Gaultier M; Prouillet F
    Nouv Presse Med; 1975 Apr; 4(17):1293. PubMed ID: 1153293
    [No Abstract]   [Full Text] [Related]  

  • 24. [Letter: Encephalopathies caused by bismuth].
    Barbizet J; Degos JD; Bouchareine A
    Nouv Presse Med; 1975 Apr; 4(17):1290-1. PubMed ID: 1153289
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bismuth myoclonic encephalopathy. Report of two cases (author's transl)].
    Cervelló MA; Alfaro A; Antolín MA; Peñarrocha M
    Med Clin (Barc); 1982 Jul 1-31; 79(3):137-40. PubMed ID: 7109770
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bismuth treatment and blood bismuth levels].
    Hillemand P; Pallière M; Laquais B; Bouvet P
    Sem Hop; 1977 Sep; 53(31-32):1663-9. PubMed ID: 198893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Letter: Bismuth induced encephalopathy in a pregnant woman].
    Quereux C; Ezes H; Wahl P; Morice J; Level G
    Nouv Presse Med; 1975 Sep; 4(31):2275. PubMed ID: 1178500
    [No Abstract]   [Full Text] [Related]  

  • 28. [Letter: Bismuth induced encephalopathy in a pregnant woman. Birth of a normal child].
    Cambier J; Le Bigot P; Thoyer-Rozat ; Irondelle D; Levardon M
    Nouv Presse Med; 1975 Sep; 4(31):2275. PubMed ID: 1178499
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment].
    Nogué S; Mas A; Parés A; Nadal P; Bertrán A; Torra M; Bachs M; Blesa R
    Med Clin (Barc); 1985 Apr; 84(13):530-2. PubMed ID: 3999823
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute fatal encephalopathy with osteonecrosis of both humeral heads following the ingestion of minimal doses of insoluble bismuth salts (author's transl)].
    Lhermitte F; Mallecourt J; Chedru F; Kuperwasser B; Glaser P
    Nouv Presse Med; 1978 Jun; 7(24):2170-1. PubMed ID: 683868
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.
    Supino-Viterbo V; Sicard C; Risvegliato M; Rancurel G; Buge A
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):748-52. PubMed ID: 336849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Letter: Encephalopathies during treatment with bismuth or the mishaps of"conjugated" bismuth therapy].
    Raverdy P; Smagghe A; Marie JP; Prinseau J
    Nouv Presse Med; 1975 Apr; 4(14):1050. PubMed ID: 805409
    [No Abstract]   [Full Text] [Related]  

  • 33. Bismuth encephalopathy.
    Monseu G; Struelens M; Roland M
    Acta Neurol Belg; 1976; 76(5-6):301-8. PubMed ID: 1007897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advantages and disadvantages of bismuth salts in digestive therapy].
    Maison E
    Med Chir Dig; 1977; 6(3):167-70. PubMed ID: 895245
    [No Abstract]   [Full Text] [Related]  

  • 35. [Psychiatric aspects of encephalopathy caused by bismuth salts].
    Bertaud M; Mangin P; Charlin A
    Ann Med Psychol (Paris); 1976 May; 1(5):717-21. PubMed ID: 970827
    [No Abstract]   [Full Text] [Related]  

  • 36. [Encephalopathy caused by bismuth has not disappeared...].
    Vidailhet M; Le TH; Wechsler B; Godeau P
    Presse Med; 1987 Jun; 16(21):1054. PubMed ID: 2955328
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bismuth-induced encephalopathies. Report and commentaries apropos of 15 cases in the Lyon area].
    Moindrot J; Evreux JC; Savet JF; Aimard G
    Lyon Med; 1977 Dec; 238(20):537-41. PubMed ID: 599952
    [No Abstract]   [Full Text] [Related]  

  • 38. [Myoclonic encephalopathy due to bismuth subnitrate. A recent case].
    Goas JY; Borsotti JP; Missoum A; Allain P; Chaleil D
    Nouv Presse Med; 1981 Dec; 10(47):3855. PubMed ID: 7329800
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myoclonic encephalopathy caused by bismuth].
    Gómez Jiménez J; Alvarez J; Boada Rovira M; Codina-Puiggros A
    Rev Clin Esp; 1989 Mar; 184(4):212. PubMed ID: 2740555
    [No Abstract]   [Full Text] [Related]  

  • 40. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.
    Gordon MF; Abrams RI; Rubin DB; Barr WB; Correa DD
    Mov Disord; 1995 Mar; 10(2):220-2. PubMed ID: 7753066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.